BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32770123)

  • 21. [Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion].
    Li HL; Mo CH; Xie L; Wu YX; Zeng M; Mao RJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):58-63. PubMed ID: 38178748
    [No Abstract]   [Full Text] [Related]  

  • 22. A unique epithelioid vascular neoplasm of bone characterized by EWSR1/FUS-NFATC1/2 fusions.
    Dashti NK; Dickson BC; Zhang L; Xie Z; Nielsen GP; Antonescu CR
    Genes Chromosomes Cancer; 2021 Nov; 60(11):762-771. PubMed ID: 34310785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
    Dermawan JK; Torrence D; Lee CH; Villafania L; Mullaney KA; DiNapoli S; Sukhadia P; Benayed R; Borsu L; Agaram NP; Nash GM; Dickson BC; Benhamida J; Antonescu CR
    Genes Chromosomes Cancer; 2022 Oct; 61(10):592-602. PubMed ID: 35665561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.
    Antonescu CR; Dal Cin P; Nafa K; Teot LA; Surti U; Fletcher CD; Ladanyi M
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1051-60. PubMed ID: 17724745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
    Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2.
    Hiemenz MC; Kaur J; Kuang Z; Huang RSP; Harries L; Metzger D; Schiavone K; Millis SZ; Lin DI; Lechpammer M; Decker B; Mata DA; Reddy A; Parke M; Lee EY; Cui X; Iwenofu OH; Buehler D; Henderson L; Baldwin EM; Boikos SA; Ramkissoon SH; Smith SC
    Genes Chromosomes Cancer; 2023 Aug; 62(8):460-470. PubMed ID: 36862145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.
    Antonescu CR; Dickson BC; Zhang L; Sung YS; Fletcher CD
    Mod Pathol; 2021 Aug; 34(8):1541-1546. PubMed ID: 33859361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
    Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
    Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EWSR1-CREM fusion in pulmonary mesenchymal neoplasm showing distinctive clear cell morphology.
    Komatsu M; Sakai Y; Nishikubo M; Tane S; Nishio W; Kajimoto K; Hirose T
    Pathol Int; 2020 Dec; 70(12):1020-1026. PubMed ID: 33002291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial myxoid angiomatoid fibrous histiocytoma with "classic" histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors.
    Tan NJH; Pratiseyo PD; Wahjoepramono EJ; Kuick CH; Goh JY; Chang KTE; Tan CL
    Neuropathology; 2021 Aug; 41(4):306-314. PubMed ID: 34254369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates.
    Dermawan JK; Vanoli F; Herviou L; Sung YS; Zhang L; Singer S; Tap WD; Benayed R; Bale TA; Benhamida JK; Dickson BC; Antonescu CR
    Mod Pathol; 2022 Aug; 35(8):1055-1065. PubMed ID: 35347249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions.
    Lee PH; Kao YC; Hsieh TH; Liao JB; Li CF; Lee JC; Chang YM; Chang CD; Huang SC; Chen TJ; Liu TT; Yu SC; Huang HY
    Pathol Res Pract; 2022 Jan; 229():153700. PubMed ID: 34929603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of intracranial myxoid mesenchymal tumor with EWSR1:CREM fusion in an adult female: Extensive immunohistochemical evaluation.
    Kambe A; Kuwamoto S; Shimizu T; Amisaki H; Sakamoto M; Inagaki H; Kurosaki M
    Neuropathology; 2021 Aug; 41(4):315-323. PubMed ID: 34258808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcomas with sclerotic epithelioid phenotype harboring novel EWSR1-SSX1 fusions.
    Antonescu CR; Rosenberg AE; Xie Z; Zhang L; Perell KA; Loya AC
    Genes Chromosomes Cancer; 2021 Sep; 60(9):616-622. PubMed ID: 33987888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor.
    Mezzacappa FM; Smith FK; Zhang W; Gard A; Cabuk FK; Gonzalez-Gomez I; Monforte HL; Liang J; Singh O; Quezado MM; Aldape KD; Gokden M; Bridge JA; Chen J
    Acta Neuropathol Commun; 2024 Jan; 12(1):17. PubMed ID: 38291529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.
    Antonescu CR; Nafa K; Segal NH; Dal Cin P; Ladanyi M
    Clin Cancer Res; 2006 Sep; 12(18):5356-62. PubMed ID: 17000668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review.
    Gareton A; Pierron G; Mokhtari K; Tran S; Tauziède-Espariat A; Pallud J; Louvel G; Meary E; Capelle L; Chrétien F; Varlet P
    J Neuropathol Exp Neurol; 2018 Jul; 77(7):537-541. PubMed ID: 29788195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.
    Agaram NP; Zhang L; Sung YS; Cavalcanti MS; Torrence D; Wexler L; Francis G; Sommerville S; Swanson D; Dickson BC; Suurmeijer AJH; Williamson R; Antonescu CR
    Am J Surg Pathol; 2019 May; 43(5):695-702. PubMed ID: 30720533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors.
    Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Bräsen JH; Agaimy A; Klöppel G
    Virchows Arch; 2021 Dec; 479(6):1209-1219. PubMed ID: 34350470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.